吉林中医药2024,Vol.44Issue(3) :339-341.DOI:10.13463/j.cnki.jlzyy.2024.03.022

重构本草——泽兰

Reconstruction of Chinese materia medica--hirsute shiny bugleweed herb

王昭博 张伟 乔丽萍 王佳 王卉
吉林中医药2024,Vol.44Issue(3) :339-341.DOI:10.13463/j.cnki.jlzyy.2024.03.022

重构本草——泽兰

Reconstruction of Chinese materia medica--hirsute shiny bugleweed herb

王昭博 1张伟 2乔丽萍 1王佳 3王卉3
扫码查看

作者信息

  • 1. 中国中医科学院广安门医院代谢病研究所,北京 100053
  • 2. 中国中医科学院广安门医院代谢病研究所,北京 100053;甘肃中医药大学基础医学院,兰州 730000
  • 3. 中国中医科学院广安门医院综合科,北京 100053
  • 折叠

摘要

通过古籍文献调研、中药现代研究进展及其研究成果的梳理,结合中医临床及中药学等学科领域内的专家学者的认识及应用经验,归纳出泽兰:主要功效为活血调经,祛瘀消痈,利水消肿.症靶为水肿、月经不调.现代药理研究发现泽兰及其有效成分具有改善肝肾功能、抗凝血、抗血栓、保护胃黏膜等作用.本品无毒,血虚无瘀者慎服,孕妇禁服.临床使用剂量为6~30 g,内服时当根据不同疾病,或同一疾病的不同阶段进行辨证使用,并积极探索泽兰用量与症靶的量效关系构建.

Abstract

Through the investigation of ancient literature and the sorting of modern research achievements in traditional Chinese medicine,combined with the understanding and application experience of well-known experts and scholars in the clinical and pharmaceutical fields of traditional Chinese medicine,it is concluded that hirsute shiny bugleweed herb mainly has the following characteristics:Its effects mainly involve promoting blood circulation for regulating menstruation,dispelling blood stasis for eliminating carbuncles,inducing diuresis for removing edema.Its symptom targets are edema and menstrual disorders.Modern pharmacological studies have found that the herb and its active ingredients have positive effects on the improvement of renal function,liver function,anticoagulation,antithrombosis and the protection of gastric mucosa,etc.It is non-toxic,but patients with blood deficiency and blood stasis should take it with caution,and pregnant women are forbidden to take it.Its clinical dosage range is 6-30 g.When taken orally,it should be used according to different diseases,or different stages of the same disease,and the dose-effect relationship between its dosage and symptom targets should be actively explored and reconstructed.

关键词

泽兰/症靶/水肿/月经不调/重构本草/临床回归

Key words

hirsute shiny bugleweed herb/symptom targets/edema/menstrual disorders/reconstruction of Chinese materia medica/clinical verification

引用本文复制引用

基金项目

中国科学院学部咨询评议项目(2021-ZW10-A-017)

国家中医药管理局中医药创新团队及人才支持计划项目(ZYYCXTD-D-202001)

出版年

2024
吉林中医药
长春中医药大学

吉林中医药

CSTPCD
影响因子:0.843
ISSN:1003-5699
参考文献量28
段落导航相关论文